Introduction Coronavirus disease of 2019 (COVID-19) has resulted in millions of cases
worldwide. As the pandemic has progressed, the understanding of this disease has evolved …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to a concerning
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …

Invasive fungal infections (IFIs) can complicate the clinical course of COVID-19 and are
associated with a significant increase in mortality, especially in critically ill patients admitted …

The recent increase of COVID-19-associated mucormycosis (CAM) has been commanding
global attention. However, basic epidemiologic characteristics have not firmly been …

BACKGROUND: Till now, no meta-analysis is available to address the clinical profile, risk
factors, different interventions, and outcomes among COVID-19–associated rhino-orbito …

Materials and Methods In this retrospective study (approved by the institute ethics
committee), we describe the imaging and clinical features of three microbiologically …

Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) rapidly become a global threaten since its …

An increasing incidence of rhinoorbitocerebral mucormycosis (ROCM) among patients with
COVID-19 has recently been reported in India. We report the imaging findings for 25 patients …

Mucormycosis has become increasingly associated with COVID-19, leading to the use of the
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …

Background Acute invasive fungal sinusitis (AIFS) is an aggressive disease that requires
prompt diagnosis and multidisciplinary treatment given its rapid progression. However, there …